Guided Bone Regeneration (GBR): Membranes, Graft Materials and Indications in Modern Implantology

Guided bone regeneration (GBR) applies the biological principle of selective cell exclusion: a membrane placed between the clot and the overlying soft tissue prevents invasion by connective tissue and epithelial cells, which would quickly colonize the bone defect and inhibit regeneration. The space protected by the membrane is instead colonized by osteoprogenitor cells coming from adjacent bone tissue and bone marrow. The principle, carried over from periodontal surgery in the 1980s by Dahlin et al. (Plast Reconstr Surg, 1988), found its widest application in implantology in treating post-extraction sockets, peri-implant defects, and horizontal and vertical ridge augmentation.

Membrane classification is the starting point for rational selection. Non-resorbable expanded PTFE (ePTFE, Gore-Tex®) or high-density PTFE (dPTFE, Cytoplast®) membranes offer maximum mechanical predictability — they reliably maintain volumetric space and don't degrade during healing — but require a second surgical procedure for removal. Non-expanded dPTFE membranes show the added advantage of being exposable in the oral cavity without the bacterial colonization that characterized original ePTFE: the dense structure doesn't allow bacterial penetration into the regenerating site for brief exposures (<4 weeks). Resorbable membranes — collagen-based (Bio-Gide®, Creos®, OsseoGuard®) or polylactic-glycolic acid (PLA/PGA) — eliminate the second procedure at the cost of lower volumetric maintenance and variable degradation kinetics (6 weeks to 6 months depending on composition and site).

Filling the defect with graft material is recommended in implant-supporting GBR when the bone defect isn't self-supporting. Self-supporting defects — with rigid bone walls maintaining the space under the membrane even without filler — can be treated with a spontaneous clot or PRGF/PRF as the sole material. Non-self-supporting defects require a material with high compressive resistance and a low resorption rate to maintain space during healing: deproteinized bovine hydroxyapatite granules (dBMP, granular Bio-Oss®, 0.25-1 mm) represent the gold standard for this indication, documented over more than 15 years of follow-up. A combination of particulate autologous bone (30%) + xenogenic bone (70%) is the most-used mix, combining osteoinduction (from the autologous component) with volumetric maintenance (xenogenic).

The classification of peri-implant defects — which guides GBR technique choice — follows defect morphology: fenestration defects (the implant surface is exposed within a bony window with an intact crest), dehiscence defects (the implant surface is exposed from the crest toward the apex), and socket-wall coverage defects (in post-extraction sites with loss of the labial wall). Fenestration and dehiscence defects with favorable angulation (<30° relative to the implant axis) show the best predictability with GBR and xenogenic material + membrane. Large dehiscence defects (>5 mm vertical) require a more rigid membrane stabilization technique — titanium pins for fixation, membranes reinforced with titanium mesh (Ti-mesh), or prefabricated titanium shells — to avoid membrane collapse onto the implant surface during healing.

The timing between GBR and implant placement follows two main approaches: GBR with simultaneous implant placement ("one-stage") or delayed implant placement after graft healing ("two-stage"). The simultaneous approach is indicated when primary implant stability is achievable (ISQ ≥65, torque ≥25 N/cm) despite the defect: it reduces the number of surgical sessions and takes advantage of growth factors released at the implant site for regeneration. The delayed approach (6-9 months' wait) is indicated when primary stability isn't achievable, when the defect is too extensive for simultaneous management, or when optimizing three-dimensional implant position after complete bone regeneration is desired. Systematic reviews don't document statistically significant differences in survival rates between the two approaches at 3-5 years.

GBR complications in implantology are dominated by early membrane exposure, with an incidence of 10-30% in published case series. Exposure significantly compromises the regenerative outcome: Machtei (2001, J Periodontol) documented a 30-50% reduction in bone gain at sites with early exposure compared to controls. Prevention requires flap design ensuring tension-free closure at suturing — with periosteal releasing incisions, mobilization of the lingual flap in the mandible, management of adjacent frenula — and choosing suture materials with low bacterial biofilm attraction (nylon or PTFE monofilament, not vicryl or silk).